|
Loading...
| ||||||||||||||
Recent Publications by Merck Sharp and Dohme Neuroscience Research Centre: |  | |
| Psychiatric drug discovery and development.
This new conference on Psychiatric Drug Research was organised by the... | Merck Sharp and Dohme Neuroscience Research Centre, Department of | Expert Opin Investig Drugs. 2003 Sep;12(9):1571-5.
DOI Direct Link |
| Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
The regulation of stress-induced vocalisations by central NK(1) receptors... | Merck Sharp and Dohme Neuroscience Research Centre, Harlow, CM20 2QR, | Neuropharmacology. 2000 Jun 8;39(8):1413-21. |
| Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity.
Substance P receptor [neurokinin 1 (NK1] antagonists (SPAs) represent a... | Department of Pharmacology, Merck Sharp and Dohme Neuroscience Research | J Neurosci. 2002 Sep 1;22(17):7730-6. |
| Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
The phenotype of NK1R-/- mice was compared with that of acute... | Merck Sharp and Dohme Neuroscience Research Centre, Harlow, Essex, CM20 | Behav Pharmacol. 2001 Nov;12(6-7):497-508. |
| Neurogenic inflammation in the context of migraine.
Despite considerable research into the pathogenesis of idiopathic... | Whole Animal Pharmacology, Department of Pharmacology, Merck Sharp and | Microsc Res Tech. 2001 May 1;53(3):167-78.
DOI Direct Link |